Omdahl Pamela, Eggen Michael D, Bonner Matthew D, Iaizzo Paul A, Wika Kent
Medtronic, PLC., Mounds View, Minnesota.
Department of Surgery, University of Minnesota, Minneapolis, Minnesota.
Pacing Clin Electrophysiol. 2016 Apr;39(4):393-7. doi: 10.1111/pace.12804. Epub 2016 Feb 1.
The introduction of transcatheter pacemaker technology has the potential to significantly reduce if not eliminate a number of complications associated with a traditional leaded pacing system. However, this technology raises new questions regarding how to manage the device at end of service, the number of devices the right ventricle (RV) can accommodate, and what patient age is appropriate for this therapy. In this study, six human cadaver hearts and one reanimated human heart (not deemed viable for transplant) were each implanted with three Micra devices in traditional pacing locations via fluoroscopic imaging.
A total of six human cadaver hearts were obtained from the University of Minnesota Anatomy Bequest Program; the seventh heart was a heart not deemed viable for transplant obtained from LifeSource and then reanimated using Visible Heart(®) methodologies. Each heart was implanted with multiple Micras using imaging and proper delivery tools; in these, the right ventricular volumes were measured and recorded. The hearts were subsequently dissected to view the right ventricular anatomies and the positions and spacing between devices.
Multiple Micra devices could be placed in each heart in traditional, clinically accepted pacing implant locations within the RV and in each case without physical device interactions. This was true even in a human heart considered to be relatively small.
Although this technology is new, it was demonstrated here that within the human heart's RV, three Micra devices could be accommodated within traditional pacing locations: with the potential in some, for even more.
经导管起搏器技术的引入有可能显著减少(甚至消除)一些与传统有导线起搏系统相关的并发症。然而,这项技术引发了关于如何在设备使用寿命结束时进行管理、右心室(RV)能够容纳的设备数量以及何种患者年龄适合这种治疗等新问题。在本研究中,通过荧光透视成像,在六个人类尸体心脏和一个复苏的人类心脏(被认为不适合移植)的传统起搏位置分别植入了三个Micra设备。
从明尼苏达大学解剖学遗赠项目获得了总共六个人类尸体心脏;第七个心脏是从生命源获取的一个被认为不适合移植的心脏,然后使用可视心脏(®)方法进行复苏。使用成像和合适的输送工具在每个心脏中植入多个Micra设备;在此过程中,测量并记录右心室容积。随后对心脏进行解剖,以观察右心室解剖结构以及设备之间的位置和间距。
多个Micra设备可以放置在每个心脏的右心室传统的、临床上可接受的起搏植入位置,并且在每种情况下设备之间都没有物理相互作用。即使在一个被认为相对较小的人类心脏中也是如此。
尽管这项技术是新的,但在此证明,在人类心脏的右心室中,传统起搏位置可以容纳三个Micra设备:在某些情况下甚至可能容纳更多。